← Research library

Brain Protein Expression Profile of Semax in a Rat Model of Cerebral Ischemia–Reperfusion

Animal research · 2021

What was studied
Male Wistar rats. Figures 2–3 report 5–7 animals per group for Western blots.
Main finding
At 24 hours in a rat ischemia model, Semax lowered activated JNK in two brain regions and raised activated CREB in the subcortex by more than 1.5-fold.

Reported findings and study design

A 90-minute middle cerebral artery occlusion followed by reperfusion. The investigators compared Semax-treated rats, saline-treated rats with ischemia, and a saline-treated sham group. Protein analysis used animals with MRI-confirmed subcortical lesions in the ischemia groups.

Population or model Male Wistar rats. Figures 2–3 report 5–7 animals per group for Western blots.

Dose, route and schedule

100 μg/kg intraperitoneal Semax per injection, first immediately after artery occlusion and again 1.5 and 5 hours after reperfusion began. Control groups received saline at the same time points.

Protocol source ↗ · Original article, methods and Figures 2–3

Results · Original article, methods and Figures 2–3
MeasureResultComparison, timing and statistics
Activated JNKOver two-fold higher after ischemia than sham and more than 1.5-fold lower with Semax than with saline after ischemiaSubcortex and adjacent frontoparietal cortex · 24 hours after occlusion · p<0.05, Figure 2
Activated CREBMore than 1.5-fold higher with Semax than with saline after ischemiaSubcortex. The cortical change was not statistically significant. · 24 hours after occlusion · p<0.05, Figure 2
MMP-9 and c-Fos proteinEach fell by more than 1.5-fold with Semax compared with the saline ischemia groupFrontoparietal cortex. No significant treatment difference in subcortex. · 24 hours after occlusion · p<0.05, Figure 3

The experiment measures four selected proteins at one time point in a rat model. It provides no human treatment outcomes.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • Animal molecular endpoints do not demonstrate clinical stroke efficacy.
  • Related transcriptomic and protein studies are not automatically independent replication.

Source details

Journal publication

Original article, methods and Figures 2–3

Sources checked

Citation

Animal / experimentalEnglish abstract

Olga Yu Sudarkina, Ivan B Filippenkov, Vasily V Stavchansky, Alina E Denisova, Vadim V Yuzhakov, Larisa E Sevankaeva, Liya V Valieva, Julia A Remizova, Veronika G Dmitrieva, Leonid V Gubsky, Nikolai F Myasoedov, Svetlana A Limborska, Lyudmila V Dergunova. Brain Protein Expression Profile of Semax in a Rat Model of Cerebral Ischemia–Reperfusion Int J Mol Sci. 22(12):6179

Study source ↗ · DOI 10.3390/ijms22126179 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards